NHIC urged to clim illegal selling of generic drugs with bioequivalence data fabrication

Published: 2011-08-29 07:00:00

Updated: 2011-08-29 07:00:00

For more than three years since 2008, the National Health Insurance Corp. has staged an uphill battle with 93 pharmaceutical firms that submitted falsified bioequivalence data on 231 medicines.

In each lawsuit, the court rejected claims for compensation by the NHIC, saying that the compensatio...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK